Lowering Prescription Drug Costs: A Look at Recent Changes
For many Americans, the high cost of prescription drugs presents a significant financial burden. Recent federal changes, spurred by both the Biden and Trump administrations, aim to address this issue, with varying degrees of impact depending on individual circumstances.
Federal Initiatives to Lower Drug Prices
President Trump has emphasized lowering prescription drug costs as a key achievement, pointing to initiatives like the “most favored nation” plan and the direct-to-consumer TrumpRx program. However, experts note that some price reductions were initiated under the Biden administration or are a result of market forces, particularly for weight loss drugs 1.
Key changes include:
- Capping Out-of-Pocket Costs for Seniors: A program initiated under President Biden caps out-of-pocket prescription drug costs for seniors enrolled in Medicare Part D at $2,000 annually 2.
- Drug Pricing Program: Ongoing efforts to negotiate drug prices are intended to lower costs for a wider range of medications.
- TrumpRx: This program offers direct-to-consumer ordering of select drugs, potentially providing savings, especially for those uninsured or using medications not typically covered by insurance, such as GLP-1s and fertility drugs 2.
How TrumpRx Works and Who Benefits
TrumpRx allows consumers to purchase medications directly, potentially at lower prices. However, experts caution that individuals with insurance may not uncover significant savings, as using TrumpRx may prevent them from applying their deductible 2. Examples cited include a reduction in the price of an in-vitro fertilization (IVF) drug from $316 to $22 and a GLP-1 drug from $1,349 to $149 2.
Impact on Pharmacies
Pharmacies are navigating these changes as well. Pharmacists often see only a small profit margin on discounted prescriptions, sometimes as little as 50 cents to $2 per prescription 2. This can create challenges for maintaining profitability while providing affordable medications to patients.
Looking Ahead
The ongoing negotiation of drug prices and the evolution of programs like TrumpRx suggest a continued focus on lowering prescription drug costs. The effectiveness of these measures will depend on a variety of factors, including insurance coverage, the specific medications needed and ongoing market dynamics. Further legislative action and continued negotiation efforts are anticipated to build on these initial steps.
1 https://abcnews.com/Health/trump-wrong-drug-pricing-state-of-the-union/story?id=130488467
2 https://www.cbsnews.com/minnesota/news/federal-changes-actions-trump-prescription-drug-prices/
Related reading